Belimumab add-on therapy eased fatigue and disease activity in Saudi lupus cohort over 12 months
A prospective 12-month cohort study of 36 Saudi patients with lupus found that belimumab add-on therapy was associated with significant ...
Tag: BLyS inhibitor
POPULAR NEWS
-
Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant
-
Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast
-
ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth
-
Systematic review maps sustainability tensions in offshore wind development